Dr. Jason Alan Korenblit, MD

Dr. Korenblit practices at AdventHealth Orlando in Orlando, Florida, part of AdventHealth.

Dr. Korenblit's NPI, 1467641423, was assigned on October 16, 2007. Dr. Korenblit graduated from Sidney Kimmel Medical College in 2013. Dr. Korenblit holds Florida license ME122708.

Dr. Korenblit's primary practice is AdventHealth Orlando, at 601 E Rollins St, Orlando, FL 32803 in Orange County. The practice phone is (407) 303-1976.

Dr. Korenblit's primary practice is AdventHealth Orlando in Orlando, Florida, part of AdventHealth. Dr. Korenblit is also affiliated with Holston Valley Medical Center. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Korenblit to 3 more hospitals, 10 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Korenblit practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Korenblit's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Korenblit is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Korenblit's licenses on file in 8 states: Florida, New Mexico, Georgia, Kentucky, Tennessee, Virginia, Pennsylvania and New Jersey.

Dmand AI lists acid reflux, acute gallbladder or bile duct inflammation, chronic inflammatory bowel disease (IBD), colonoscopy, fatty liver, gastroenteritis, gastrointestinal bleeding and intestinal diverticulosis among the conditions Dr. Korenblit treats.

CMS data shows 1,294 Medicare services from Dr. Korenblit across 16 procedure codes in 2024, for 541 Medicare patients. Medicare paid $96,475 for them.

CMS counts 541 Medicare patients who saw Dr. Korenblit in 2024. The largest group is 65 to 74, with 282 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Korenblit's median patient age at 64, with 50% women.

In 2024, Dr. Korenblit wrote 1,082 Medicare Part D claims for 301 patients. 81% of them were for generic drugs. CMS names the drug for 877 of them, across 23 drugs with 11 or more claims each, at $340,391 in total drug cost. In 2023, CMS named 934 claims across 27 drugs.

Dr. Korenblit accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Korenblit as offering telehealth. CMS counts 155 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Korenblit, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 7 papers to Dr. Korenblit, published from 2012 to 2015. Dr. Korenblit's most frequent co-authors are David E. Loren, MD, Robert Frankel, MD and David M. Kastenberg, MD.

Dmand AI links Dr. Korenblit to 1 clinical trial. Conditions studied include Colitis, Ulcerative and Colitis. Open Payments lists research payments to Dr. Korenblit that name 1 trial.

CMS Open Payments shows 1,081 general payments to Dr. Korenblit from 50 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 88% of the total. Janssen Pharmaceuticals, Inc paid the most, $152,270. It also lists 1 research payment totaling $3,696 in 2021, naming 1 clinical trial.

Dr. Korenblit graduated from Sidney Kimmel Medical College in 2013.

Dr. Korenblit is in network with 17 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.